Oscar Health, Inc. (NYSE:OSCR) Insider Mario Schlosser Sells 390,405 Shares

Oscar Health, Inc. (NYSE:OSCR) insider Mario Schlosser sold 390,405 shares of the firm’s stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $7.12, for a total transaction of $2,779,683.60. Following the completion of the transaction, the insider now directly owns 57,317 shares of the company’s stock, valued at approximately $408,097.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Oscar Health Trading Up 8.8 %

Shares of NYSE OSCR traded up $0.67 during midday trading on Monday, reaching $8.28. The stock had a trading volume of 2,604,010 shares, compared to its average volume of 2,286,581. The firm has a market cap of $1.87 billion, a price-to-earnings ratio of -5.10 and a beta of 1.10. Oscar Health, Inc. has a twelve month low of $2.05 and a twelve month high of $9.89. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.36 and a current ratio of 1.36. The company’s 50 day moving average price is $5.76 and its 200 day moving average price is $6.95.

Oscar Health (NYSE:OSCR) last released its earnings results on Tuesday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.47) by $0.18. Oscar Health had a negative net margin of 6.39% and a negative return on equity of 37.51%. The company had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.42 billion. During the same quarter in the previous year, the company earned ($0.91) EPS. Oscar Health’s quarterly revenue was up 47.2% compared to the same quarter last year. As a group, sell-side analysts expect that Oscar Health, Inc. will post -1.3 EPS for the current year.

Analyst Upgrades and Downgrades

OSCR has been the subject of a number of research reports. The Goldman Sachs Group raised their target price on shares of Oscar Health from $5.50 to $7.50 and gave the stock a “neutral” rating in a research note on Thursday, August 10th. Bank of America raised shares of Oscar Health from a “neutral” rating to a “buy” rating and raised their price target for the stock from $8.00 to $9.00 in a research report on Thursday, November 2nd. Morgan Stanley raised their price target on shares of Oscar Health from $5.00 to $7.50 and gave the stock an “equal weight” rating in a research report on Wednesday, August 30th. Finally, Credit Suisse Group raised their price target on shares of Oscar Health from $7.00 to $8.50 and gave the stock an “outperform” rating in a research report on Wednesday, August 9th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $7.70.

Hedge Funds Weigh In On Oscar Health

Several institutional investors have recently added to or reduced their stakes in the stock. Amalgamated Bank lifted its holdings in shares of Oscar Health by 10.6% in the third quarter. Amalgamated Bank now owns 15,762 shares of the company’s stock worth $88,000 after buying an additional 1,516 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of Oscar Health by 3.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 45,022 shares of the company’s stock worth $295,000 after purchasing an additional 1,651 shares during the last quarter. Rhumbline Advisers increased its position in shares of Oscar Health by 0.8% in the third quarter. Rhumbline Advisers now owns 236,775 shares of the company’s stock worth $1,319,000 after purchasing an additional 1,832 shares during the last quarter. The Manufacturers Life Insurance Company increased its position in shares of Oscar Health by 4.8% in the fourth quarter. The Manufacturers Life Insurance Company now owns 50,826 shares of the company’s stock worth $125,000 after purchasing an additional 2,347 shares during the last quarter. Finally, Covestor Ltd increased its position in shares of Oscar Health by 310.0% in the second quarter. Covestor Ltd now owns 3,329 shares of the company’s stock worth $27,000 after purchasing an additional 2,517 shares during the last quarter. Institutional investors own 66.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers Individual and Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payors directly enable their shift to value-based care It also provides reinsurance products.